{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:32:23Z","timestamp":1792017143267,"version":"4.4.0"},"reference-count":436,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL127413"],"award-info":[{"award-number":["R01HL127413"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL125169"],"award-info":[{"award-number":["R01HL125169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HANES07XX0"],"award-info":[{"award-number":["HANES07XX0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HANES15G0"],"award-info":[{"award-number":["HANES15G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jconrel.2016.05.031","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T18:19:13Z","timestamp":1463422753000},"page":"465-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["Barriers to inhaled gene therapy of obstructive lung diseases: A review"],"prefix":"10.1016","volume":"240","author":[{"given":"Namho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Soo","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.05.031_bb0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/archdischild-2012-302158","article-title":"Gene therapy in cystic fibrosis","volume":"99","author":"Armstrong","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1525-0016(03)00221-1","article-title":"Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter","volume":"8","author":"Ostrowski","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI0215780","article-title":"Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins","volume":"110","author":"Auricchio","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0025","doi-asserted-by":"crossref","first-page":"14695","DOI":"10.1073\/pnas.94.26.14695","article-title":"Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways","volume":"94","author":"Chow","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1515\/hsz-2014-0160","article-title":"Generic tools for conditionally altering protein abundance and phenotypes on demand","volume":"395","author":"Faden","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0035","doi-asserted-by":"crossref","first-page":"L231","DOI":"10.1152\/ajplung.90209.2008","article-title":"Ciliated epithelial cell lifespan in the mouse trachea and lung","volume":"295","author":"Rawlins","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0040","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/hmg\/ddt013","article-title":"S\/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA","volume":"22","author":"Koirala","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14712598.2013.735656","article-title":"Expert opinion in biological therapy: update on developments in lung gene transfer","volume":"13","author":"Griesenbach","year":"2013","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2008.09.010","article-title":"Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy","volume":"61","author":"Griesenbach","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0055","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(98)06532-5","article-title":"Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial","volume":"353","author":"Alton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0060","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ng1093-135","article-title":"Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice","volume":"5","author":"Alton","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0070","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/gt.2011.55","article-title":"Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung","volume":"18","author":"McLachlan","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","article-title":"Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis","volume":"75","author":"Zabner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0080","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","article-title":"Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector","volume":"90","author":"Flotte","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(93)90028-2","article-title":"Cystic fibrosis","volume":"39","author":"Aitken","year":"1993","journal-title":"Dis. Mon."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0090","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4187\/aarc0443","article-title":"Pulmonary complications of cystic fibrosis","volume":"54","author":"Flume","year":"2009","journal-title":"Respir. Care"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2006.01744.x","article-title":"Evidence for airway surface dehydration as the initiating event in CF airway disease","volume":"261","author":"Boucher","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1255825","article-title":"Cystic fibrosis. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis","volume":"345","author":"Hoegger","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0105","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.154.5.8912731","article-title":"Cystic fibrosis","volume":"154","author":"Davis","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078593","article-title":"Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium","volume":"8","author":"Saint-Criq","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0115","first-page":"SE01","article-title":"Ivacaftor: a novel mutation modulating drug","volume":"8","author":"Kapoor","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0120","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0125","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0130","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0135","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1345\/aph.1R076","article-title":"Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment","volume":"46","author":"Pettit","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/thoraxjnl-2015-207369","article-title":"Lumacaftor\/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?","volume":"70","author":"Jones","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI117028","article-title":"Expression of the cystic fibrosis gene in adult human lung","volume":"93","author":"Engelhardt","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1172\/JCI7935","article-title":"Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus","volume":"104","author":"Harvey","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0160","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/med.20009","article-title":"Challenges and strategies: the immune responses in gene therapy","volume":"24","author":"Zhou","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","author":"Alton","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2174\/138161212799315993","article-title":"Progress in gene and cell therapy for cystic fibrosis lung disease","volume":"18","author":"Griesenbach","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2012.12.001","article-title":"Gene therapy in cystic fibrosis","volume":"161","author":"Prickett","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"Johnson","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium","volume":"7","author":"Zhang","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nbt.1769","article-title":"Gene therapy finds its niche","volume":"29","author":"Sheridan","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2015.56","article-title":"miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells","author":"Kumar","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0200","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/ncomms7952","article-title":"Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium","volume":"6","author":"McNeer","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/biores.2012.0218","article-title":"Correction of the DeltaF508 mutation in the cystic fibrosis transmembrane conductance regulator gene by zinc-finger nuclease homology-directed repair","volume":"1","author":"Lee","year":"2012","journal-title":"BioResearch Open Access"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0210","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2015.07.062","article-title":"Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs","volume":"12","author":"Firth","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0215","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","article-title":"Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis","volume":"6","author":"Corvol","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0220","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1093\/hmg\/ddr156","article-title":"Gene therapy for alpha-1 antitrypsin deficiency","volume":"20","author":"Flotte","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0225","doi-asserted-by":"crossref","first-page":"39002","DOI":"10.1074\/jbc.M508652200","article-title":"Accumulation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NF kappa B, and BAP31 but not the unfolded protein response","volume":"280","author":"Hidvegi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0230","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molmed.2013.11.006","article-title":"alpha-1-Antitrypsin deficiency: clinical variability, assessment, and treatment","volume":"20","author":"Stockley","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2016.05.031_bb0235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/15412555.2013.764978","article-title":"Gene-based therapy for alpha-1 antitrypsin deficiency","volume":"10","author":"Mueller","year":"2013","journal-title":"COPD"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0240","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/10430340050015338","article-title":"Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy","volume":"11","author":"Brigham","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0245","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0250","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1517\/14712598.5.3.333","article-title":"Gene therapy for chronic obstructive pulmonary disease: twilight or triumph?","volume":"5","author":"Al-Jamal","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.109.1.115","article-title":"Woodsmoke exposure and risk for obstructive airways disease among women","volume":"109","author":"Dennis","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0265","first-page":"249","article-title":"Current knowledge on pathogenesis and pathologic anatomy of chronic obstructive pulmonary disease","volume":"93","author":"Turato","year":"2002","journal-title":"Recenti Prog. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1741-7015-11-181","article-title":"Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease","volume":"11","author":"Wedzicha","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0275","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/archinte.160.11.1683","article-title":"Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988\u20131994","volume":"160","author":"Mannino","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0280","first-page":"411","article-title":"Chronic obstructive pulmonary disease: epidemiology, management, and impact on North Carolina","volume":"74","author":"Gegick","year":"2013","journal-title":"N. C. Med. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256664","article-title":"Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents","volume":"2","author":"Poole","year":"2003","journal-title":"Am. J. Respir. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0290","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1183\/09031936.01.17509950","article-title":"Bacteria, antibiotics and COPD","volume":"17","author":"Wilson","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0295","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cyto.2015.04.008","article-title":"Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD)","volume":"74","author":"Dima","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0300","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/hmg\/ddh171","article-title":"The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)","volume":"13","author":"Celedon","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0305","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.200509-1452OC","article-title":"Genetic association analysis of functional impairment in chronic obstructive pulmonary disease","volume":"173","author":"Hersh","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1165\/rcmb.2008-0427OC","article-title":"Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema","volume":"41","author":"Hersh","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0315","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature01413","article-title":"Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema","volume":"422","author":"Morris","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0320","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1164\/ajrccm.163.6.9908135","article-title":"Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)","volume":"163","author":"Takizawa","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0325","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/path.2548","article-title":"Fibrillin-1 staining anomalies are associated with increased staining for TGF-beta and elastic fibre degradation; new clues to the pathogenesis of emphysema","volume":"218","author":"Koenders","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0330","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI46215","article-title":"Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice","volume":"122","author":"Podowski","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0335","first-page":"L530","article-title":"Cigarette smoke and CFTR: implications in the pathogenesis of COPD","volume":"305","author":"Rab","year":"2013","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0340","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jaci.2009.10.071","article-title":"Genetics of allergic disease","volume":"125","author":"Holloway","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0345","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11882-011-0177-8","article-title":"Gene therapy for allergic airway diseases","volume":"11","author":"Maes","year":"2011","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0350","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1164\/rccm.201210-1853PP","article-title":"Inhaled corticosteroids in lung diseases","volume":"187","author":"Raissy","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0355","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/ACI.0b013e328362a775","article-title":"Long-acting anticholinergics in the treatment of asthma","volume":"13","author":"Guyer","year":"2013","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0360","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1183\/09031936.00112107","article-title":"The response to combination therapy treatment regimens in severe\/difficult-to-treat asthma","volume":"32","author":"Campbell","year":"2008","journal-title":"Eur. Respir. J"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0365","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0370","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nbt.1994","article-title":"Attacks on asthma","volume":"29","author":"Webb","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0375","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4155\/fmc.11.108","article-title":"Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases","volume":"3","author":"Ferrari","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0380","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jaci.2005.07.011","article-title":"Airway remodeling contributes to the progressive loss of lung function in asthma: an overview","volume":"116","author":"Pascual","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0385","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2014.02.010","article-title":"DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma","volume":"180","author":"da Silva","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0390","first-page":"412","article-title":"Neuroendocrine control of thymus physiology","volume":"21","author":"Savino","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0395","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/02770903.2010.514635","article-title":"The effects of antisense interleukin-4 gene transferred by recombinant adeno-associated virus vector on the airway remodeling in allergic rats","volume":"47","author":"Cao","year":"2010","journal-title":"J. Asthma"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0400","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOL.0b013e3283555a7e","article-title":"Gene therapy for lipoprotein lipase deficiency","volume":"23","author":"Gaudet","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0405","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.gt.3302809","article-title":"Gene therapy progress and prospects: cystic fibrosis","volume":"13","author":"Griesenbach","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0410","series-title":"Viruses","first-page":"847","article-title":"Latest Insights on Adenovirus Structure and Assembly","author":"Mart\u00edn","year":"2012"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0415","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.gt.3302071","article-title":"Gene therapy progress and prospects: adenoviral vectors","volume":"10","author":"George","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0420","series-title":"Molecular Therapy","first-page":"5","article-title":"Chance or Necessity? Insertional Mutagenesis in Gene Therapy and Its Consequences","author":"Baum","year":"2004"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2016.05.031_bb0425","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S1569-1993(11)60017-9","article-title":"Gene and cell therapy for cystic fibrosis: from bench to bedside","volume":"10","author":"Conese","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0430","doi-asserted-by":"crossref","first-page":"10219","DOI":"10.1074\/jbc.274.15.10219","article-title":"Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia","volume":"274","author":"Walters","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0435","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/JVI.69.4.2004-2015.1995","article-title":"Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses","volume":"69","author":"Yang","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0440","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0445","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/gt.2008.14","article-title":"Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors","volume":"15","author":"Brunetti-Pierri","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0450","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/156652321305131212125338","article-title":"Helper dependent adenovirus vectors: progress and future prospects","volume":"13","author":"Cots","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0455","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1525-0016(03)00059-5","article-title":"Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter","volume":"7","author":"Toietta","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0460","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.gt.3302712","article-title":"Readministration of helper-dependent adenovirus to mouse lung","volume":"13","author":"Koehler","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0465","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/humc.2014.154","article-title":"Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0470","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.55","article-title":"Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors.","volume":"2","author":"Cao","year":"2013","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0475","first-page":"1","article-title":"AAV at 50: a golden anniversary of discovery, research, and gene therapy success, a personal perspective","volume":"265","author":"Hastie","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0480","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of adeno-associated virus (AAV) and recombinant AAV vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0485","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0490","doi-asserted-by":"crossref","first-page":"20610","DOI":"10.1074\/jbc.M101559200","article-title":"Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer","volume":"276","author":"Walters","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0495","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0500","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1128\/JVI.00895-06","article-title":"Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0505","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/104303403322124792","article-title":"Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study","volume":"14","author":"Flotte","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0510","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/104303402760128577","article-title":"A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies","volume":"13","author":"Wagner","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0515","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0520","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1128\/JVI.74.8.3852-3858.2000","article-title":"Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer","volume":"74","author":"Zabner","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0525","article-title":"Noninvasive imaging reveals stable transgene expression in mouse airways after delivery of a nonintegrating recombinant adeno-associated viral vector","author":"Vidovi\u0107","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0530","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/sj.mt.6300277","article-title":"Biological differences in rAAV transduction of airway epithelia in humans and in old world non-human primates","volume":"15","author":"Liu","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0535","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mt.2009.230","article-title":"Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway","volume":"18","author":"Flotte","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0540","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/mt.2010.51","article-title":"Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs","volume":"18","author":"Halbert","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0545","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/mt.2008.261","article-title":"Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro","volume":"17","author":"Limberis","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0550","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.physiol.65.092101.142426","article-title":"Current status of gene therapy for inherited lung diseases","volume":"65","author":"Driskell","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0555","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.79.1.364-379.2005","article-title":"Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes","volume":"79","author":"Yan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0560","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/mt.2013.92","article-title":"A novel chimeric adenoassociated virus 2\/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia","volume":"21","author":"Yan","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0565","first-page":"832","article-title":"Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector","volume":"15","author":"Sirninger","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085183","article-title":"Correcting the cystic fibrosis disease mutant, A455E CFTR","volume":"9","author":"Cebotaru","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0575","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1074\/jbc.M112.420489","article-title":"Transcomplementation by a truncation mutant of cystic fibrosis transmembrane conductance regulator (CFTR) enhances DeltaF508 processing through a biomolecular interaction","volume":"288","author":"Cebotaru","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0580","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.mt.6300059","article-title":"Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates","volume":"15","author":"Fischer","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0585","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/mthe.2001.0456","article-title":"Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison","volume":"4","author":"Duan","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0590","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nbt0702-697","article-title":"Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene","volume":"20","author":"Halbert","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0595","first-page":"1","article-title":"Transduction of genes using retrovirus vectors: overview of the retrovirus transduction","author":"Cepko C","year":"2001","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0600","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1126\/science.299.5605.320","article-title":"Gene therapy. Second child in French trial is found to have leukemia","volume":"299","author":"Marshall","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0605","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0610","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0958-1669(98)80029-3","article-title":"Lentiviruses as gene transfer agents for delivery to non-dividing cells","author":"Naldini","year":"1998","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0615","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1021022629126","article-title":"Determinants for lentiviral infection of non-dividing cells","author":"Vodicka","year":"2001","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0620","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BJ20120146","article-title":"Lentiviral vectors: basic to translational","volume":"443","author":"Sakuma","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0625","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/srep01287","article-title":"Airway gene transfer in a non-human primate: lentiviral gene expression in marmoset lungs","volume":"3","author":"Farrow","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0630","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.gt.3301138","article-title":"Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo","volume":"7","author":"Johnson","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0635","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1089\/10430340260355365","article-title":"Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer.","volume":"13","author":"Limberis","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0640","doi-asserted-by":"crossref","DOI":"10.1172\/JCI8390","article-title":"Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect","volume":"104","author":"Wang","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0645","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2466-14-183","article-title":"Transduction of ferret airway epithelia using a pre-treatment and lentiviral gene vector","volume":"14","author":"Cmielewski","year":"2014","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0650","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/mt.2010.13","article-title":"Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes","volume":"18","author":"Mitomo","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0655","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.201206-1056OC","article-title":"Assessment of F\/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy","volume":"186","author":"Griesenbach","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0660","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2011.07.013","article-title":"Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies","volume":"427","author":"Wang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0665","doi-asserted-by":"crossref","DOI":"10.2217\/nnm.15.194","article-title":"Could recent advances in DNA-loaded nanoparticles lead to effective inhaled gene therapies?","author":"Suk","year":"2016","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0670","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.21","article-title":"Cell-type-specific, aptamer-functionalized agents for targeted disease therapy","volume":"3","author":"Zhou","year":"2014","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0680","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/ar200248u","article-title":"Bioreducible polymers for gene silencing and delivery","volume":"45","author":"Son","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0685","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0690","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0695","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nmat1645","article-title":"Polymers for gene delivery across length scales","volume":"5","author":"Putnam","year":"2006","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0700","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00000441-198910000-00013","article-title":"In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle","volume":"298","author":"Brigham","year":"1989","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0705","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/ajrcmb\/4.3.206","article-title":"Localization and induced expression of fusion genes in the rat lung","volume":"4","author":"Hazinski","year":"1991","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0710","doi-asserted-by":"crossref","first-page":"11277","DOI":"10.1073\/pnas.89.23.11277","article-title":"Aerosol gene delivery in vivo","volume":"89","author":"Stribling","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0715","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/nar\/20.12.3233","article-title":"Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer","volume":"20","author":"Yoshimura","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0720","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/ajrcmb.10.1.8292378","article-title":"Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits","volume":"10","author":"Canonico","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0725","first-page":"38","article-title":"Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium","volume":"2","author":"Logan","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0730","doi-asserted-by":"crossref","first-page":"11454","DOI":"10.1073\/pnas.93.21.11454","article-title":"A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung","volume":"93","author":"Wheeler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0735","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1089\/hum.1996.7.14-1701","article-title":"Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung","volume":"7","author":"Lee","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0740","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/hum.2015.027","article-title":"Cystic fibrosis gene therapy in the UK and elsewhere","volume":"26","author":"Griesenbach","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0745","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/362250a0","article-title":"Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy","volume":"362","author":"Hyde","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0750","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nm0195-39","article-title":"Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"1","author":"Caplen","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0755","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/sj.gt.3301212","article-title":"Repeat administration of DNA\/liposomes to the nasal epithelium of patients with cystic fibrosis","volume":"7","author":"Hyde","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0760","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.gt.3300390","article-title":"Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Porteous","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0765","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/hum.1997.8.6-689","article-title":"Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung","volume":"8","author":"Scheule","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0770","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/hum.1997.8.3-313","article-title":"Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes","volume":"8","author":"Eastman","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0775","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/hum.1997.8.6-765","article-title":"A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung","volume":"8","author":"Eastman","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0780","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-3659(02)00355-3","article-title":"Mobility and stability of gene complexes in biogels","volume":"87","author":"Sanders","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0785","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/104303401750148667","article-title":"A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis","volume":"12","author":"Ruiz","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0790","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt1399","article-title":"CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression","volume":"26","author":"Hyde","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0795","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2015.07.003","article-title":"Nanocomplexes for gene therapy of respiratory diseases: targeting and overcoming the mucus barrier","author":"Di Gioia","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0805","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/17425247.2013.744964","article-title":"Novel polyethylenimine-derived nanoparticles for in vivo gene delivery","volume":"10","author":"Patnaik","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0810","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jgm.696","article-title":"Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis","volume":"7","author":"Akinc","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0815","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1016\/j.biomaterials.2012.04.019","article-title":"The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA\/PEI complexes","volume":"33","author":"Davies","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0820","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/mthe.1999.0021","article-title":"Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization","volume":"1","author":"Densmore","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0825","first-page":"163","article-title":"Polyethylenimine-mediated gene delivery to the lung and therapeutic applications","volume":"2","author":"Di Gioia","year":"2009","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0830","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/mthe.2001.0300","article-title":"Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes","volume":"3","author":"Gautam","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0835","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1021\/ja015867r","article-title":"Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture","volume":"123","author":"Dauty","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0840","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ymthe.2005.03.002","article-title":"Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium","volume":"12","author":"Rudolph","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0845","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/mt.2008.96","article-title":"Enhanced lung gene expression after aerosol delivery of concentrated pDNA\/PEI complexes","volume":"16","author":"Davies","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0850","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1521-2254(200007\/08)2:4<269::AID-JGM112>3.0.CO;2-F","article-title":"In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers","volume":"2","author":"Rudolph","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0855","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/mthe.2001.0413","article-title":"Effects of linear polyethylenimine and polyethylenimine\/DNA on lung function after airway instillation to rat lungs","volume":"4","author":"Uduehi","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0860","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2004.11.008","article-title":"Polyethylenimine with acid-labile linkages as a biodegradable gene carrier","volume":"103","author":"Kim","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0865","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/bc034014g","article-title":"A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery","volume":"14","author":"Forrest","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0870","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/bc800451j","article-title":"Influence of disulfide density and molecular weight on disulfide cross-linked polyethylenimine as gene vectors","volume":"20","author":"Peng","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0875","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1208\/s12248-009-9122-3","article-title":"Influence of the molecular weight of bioreducible oligoethylenimine conjugates on the polyplex transfection properties","volume":"11","author":"Yu","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0880","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/jgm.598","article-title":"Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer","volume":"6","author":"Boeckle","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0885","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.juro.2013.12.011","article-title":"DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer","volume":"191","author":"Gofrit","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0890","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2013.07.081","article-title":"Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer","volume":"131","author":"Anwer","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0895","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/smll.201202485","article-title":"Nanoparticles for gene delivery","volume":"9","author":"Tian","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.05.031_bb0900","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M305776200","article-title":"Nanoparticles of compacted DNA transfect postmitotic cells","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0905","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ymthe.2003.07.007","article-title":"Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo","volume":"8","author":"Ziady","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0910","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.mt.6300365","article-title":"Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA","volume":"16","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0915","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ymthe.2003.09.002","article-title":"Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung","volume":"8","author":"Ziady","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0920","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.gt.3302761","article-title":"Plasmid size up to 20kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles","volume":"13","author":"Fink","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0925","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1089\/104303401753153956","article-title":"A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease","volume":"12","author":"Aitken","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0930","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0935","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0940","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1128\/JVI.72.7.6014-6023.1998","article-title":"Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer","volume":"72","author":"Pickles","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0945","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1074\/jbc.272.2.1117","article-title":"Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells","volume":"272","author":"Matsui","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0950","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1089\/hum.1998.9.18-2761","article-title":"Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia","volume":"9","author":"Duan","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0955","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0960","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/bc200296q","article-title":"Pulmonary gene delivery using polymeric nonviral vectors","volume":"23","author":"Merkel","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0965","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tibtech.2004.09.009","article-title":"Non-viral vectors in cystic fibrosis gene therapy: progress and challenges","volume":"22","author":"Montier","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0970","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/mt.2012.32","article-title":"Advances in cell and gene-based therapies for cystic fibrosis lung disease","volume":"20","author":"Oakland","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0975","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2008.09.011","article-title":"Extracellular barriers in respiratory gene therapy","volume":"61","author":"Sanders","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0980","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0985","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/jappl.1975.39.3.487","article-title":"Mucociliary tracheal transport rates in man","volume":"39","author":"Yeates","year":"1975","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0990","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09059180.00002710","article-title":"Revisited role for mucus hypersecretion in the pathogenesis of copd","volume":"19","author":"Cerveri","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb0995","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1000","first-page":"1134","article-title":"Physiology of airway mucus secretion and pathophysiology of hypersecretion","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir. Care"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1005","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1164\/ajrccm.162.5.9909009","article-title":"Cystic fibrosis sputum: a barrier to the transport of nanospheres","volume":"162","author":"Sanders","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1010","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010525","article-title":"Oxidation increases mucin polymer cross-links to stiffen airway mucus gels","volume":"7","author":"Yuan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/ajrccm.154.4.8887607","article-title":"Systemic oxidative stress in asthma","volume":"154","author":"Rahman","year":"1996","journal-title":"COPD Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1030","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1035","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0006-3495(03)74649-9","article-title":"Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope","volume":"85","author":"Braeckmans","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1040","first-page":"4025","article-title":"17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia","volume":"118","author":"Coakley","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12016-011-8280-0","article-title":"Environmental tobacco smoke and progesterone alter lung inflammation and mucous metaplasia in a mouse model of allergic airway disease","volume":"43","author":"Mitchell","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019919","article-title":"Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients","volume":"6","author":"Hida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1055","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/mt.2014.89","article-title":"Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors","volume":"22","author":"Schuster","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2011.08.031","article-title":"Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation","volume":"157","author":"Boylan","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1065","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/mt.2011.160","article-title":"N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles","volume":"19","author":"Suk","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2014.01.007","article-title":"Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier","volume":"178C","author":"Suk","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1075","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/anie.201208556","article-title":"Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers","volume":"52","author":"Kim","year":"2013","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1080","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/sj.gt.3301525","article-title":"Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium","volume":"8","author":"Ferrari","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1085","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.gt.3300840","article-title":"The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium","volume":"6","author":"Kitson","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0006-3495(94)80802-1","article-title":"Antibody diffusion in human cervical mucus","volume":"66","author":"Saltzman","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1095","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1100","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2013.120","article-title":"IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1105","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/hum.2006.17.440","article-title":"Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: implications for gene therapy using AAV vectors","volume":"17","author":"Halbert","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1570-0232(02)00114-9","article-title":"Database of bronchoalveolar lavage fluid proteins","volume":"771","author":"Noel-Georis","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1125","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/jgm.1255","article-title":"Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs","volume":"10","author":"Nguyen","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1015139527747","article-title":"On the transport of lipoplexes through cystic fibrosis sputum","volume":"19","author":"Sanders","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-83-2-291","article-title":"Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells","volume":"83","author":"Mardberg","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1140","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/JVI.65.3.1543-1550.1991","article-title":"Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions","volume":"65","author":"Callahan","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1145","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","author":"Suk","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.gt.3300556","article-title":"The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro","volume":"5","author":"Stern","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1155","first-page":"834","article-title":"Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation","volume":"3","author":"Crook","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/2047-783X-14-7-304","article-title":"Airway surface liquid contains endogenous DNase activity which can be activated by exogenous magnesium","volume":"14","author":"Rosenecker","year":"2009","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/pupt.2002.0351","article-title":"Mucociliary transport and cough in humans","volume":"15","author":"Foster","year":"2002","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/01926230601060025","article-title":"Cystic fibrosis and other respiratory diseases of impaired mucus clearance","volume":"35","author":"Livraghi","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-5193(86)80098-4","article-title":"Muco-ciliary transport in the lung","volume":"121","author":"Fulford","year":"1986","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11538-006-9177-6","article-title":"A viscoelastic traction layer model of muco-ciliary transport","volume":"69","author":"Smith","year":"2007","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/089426803321919915","article-title":"Airway retention of materials of different solubility following local intrabronchial deposition in dogs","volume":"16","author":"Lay","year":"2003","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1190","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1223012","article-title":"A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia","author":"Button","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1195","first-page":"915","article-title":"The role of the respiratory mucosa in health and disease","volume":"50","author":"Hilding","year":"1967","journal-title":"Minn. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/mi.2012.81","article-title":"Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways","volume":"6","author":"Kesimer","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1205","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0092-8674(00)81724-9","article-title":"Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease","volume":"95","author":"Matsui","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1165\/rcmb.2006-0082SF","article-title":"Effective mucus clearance is essential for respiratory health","volume":"35","author":"Randell","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1215","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4049\/jimmunol.181.3.2203","article-title":"The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model","volume":"181","author":"Nakagami","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1220","first-page":"69","article-title":"Alveolar macrophage kinetics after inhalation of 239PuO2 by CBA\/Ca mice: changes in synthesis of DNA","volume":"97","author":"Kellington","year":"1992","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.09.036","article-title":"Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI","volume":"109","author":"Kleemann","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2009.07.017","article-title":"Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells","volume":"140","author":"Nguyen","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1999.1458","article-title":"Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro","volume":"264","author":"Kukowska-Latallo","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<331::AID-JGM60>3.0.CO;2-8","article-title":"Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant","volume":"1","author":"Ernst","year":"1999","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1245","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/hum.1997.8.7-817","article-title":"Surfactant inhibits cationic liposome-mediated gene transfer","volume":"8","author":"Tsan","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/hum.1997.8.4-431","article-title":"Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro","volume":"8","author":"Duncan","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.gt.3301663","article-title":"Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus","volume":"9","author":"Sanders","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1260","first-page":"775","article-title":"Surfactant enhances adenovirus-mediated gene expression in rabbit lungs","volume":"3","author":"Jobe","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1265","first-page":"L741","article-title":"Exosurf enhances adenovirus-mediated gene transfer to alveolar type II cells","volume":"273","author":"Manuel","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1270","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.immuni.2006.03.008","article-title":"Alveolar macrophage in the driver's seat","volume":"24","author":"Lambrecht","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1165\/ajrcmb\/6.2.235","article-title":"Allometric relationships of cell numbers and size in the mammalian lung","volume":"6","author":"Stone","year":"1992","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/thx.47.6.437","article-title":"Intra-alveolar macrophage numbers in current smokers and non-smokers: a morphometric study of tissue sections","volume":"47","author":"Wallace","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.34.1.219","article-title":"Phagocytosis of latex beads by Acanthamoeba. II. Electron microscopic study of the initial events","volume":"34","author":"Korn","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1290","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/10611860600834375","article-title":"Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes","volume":"14","author":"Chono","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1295","first-page":"625","article-title":"Alveolar clearance and the role of the pulmonary lymphatics","volume":"115","author":"Lauweryns","year":"1977","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfv005","article-title":"Influence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lung","volume":"144","author":"Anderson","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1305","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers' entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","article-title":"Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage","volume":"9","author":"Tabata","year":"1988","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1315","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchromb.2004.10.029","article-title":"Proteomics of bronchoalveolar lavage fluid","volume":"815","author":"Wattiez","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1320","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1016\/j.biomaterials.2006.03.039","article-title":"Parameters influencing the stealthiness of colloidal drug delivery systems","volume":"27","author":"Vonarbourg","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1325","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/hum.1997.8.9-1087","article-title":"Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia","volume":"8","author":"McCray","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1330","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1128\/JVI.74.20.9655-9667.2000","article-title":"Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection","volume":"74","author":"Zsengeller","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1335","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/JVI.71.1.624-629.1997","article-title":"Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ","volume":"71","author":"Wolff","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jgm.291","article-title":"Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins","volume":"5","author":"Rosenecker","year":"2003","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1345","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/ajrccm\/141.2.471","article-title":"Macrophages and polymorphonuclear neutrophils in lung defense and injury","volume":"141","author":"Sibille","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1350","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jcf.2010.04.006","article-title":"Characterization of macrophage activation states in patients with cystic fibrosis","volume":"9","author":"Murphy","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1355","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.4049\/jimmunol.0900473","article-title":"Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease","volume":"183","author":"Shaykhiev","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1360","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1165\/ajrcmb.23.5.4164","article-title":"Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate","volume":"23","author":"Coyne","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1365","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jgm.1025","article-title":"Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors","volume":"9","author":"Kremer","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.R-07-154","article-title":"The airway epithelium is central to the pathogenesis of asthma","volume":"57","author":"Holgate","year":"2008","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1375","article-title":"Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-beta","author":"Schamberger","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1380","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1165\/ajrcmb\/9.2.148","article-title":"Structural alterations of airway epithelial tight junctions in cystic fibrosis: comparison of transplant and postmortem tissue","volume":"9","author":"Godfrey","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1385","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yexmp.2009.09.018","article-title":"CFTR and tight junctions in cultured bronchial epithelial cells","volume":"88","author":"Nilsson","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1390","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1091\/mbc.E02-03-0134","article-title":"Regulation of airway tight junctions by proinflammatory cytokines","volume":"13","author":"Coyne","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1395","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1016\/j.febslet.2006.11.057","article-title":"Pseudomonas aeruginosa quorum sensing molecule N-(3 oxododecanoyl)-l-homoserine lactone disrupts epithelial barrier integrity of Caco-2 cells","volume":"580","author":"Vikstrom","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1400","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1749-6632.2012.06533.x","article-title":"Claudins and alveolar epithelial barrier function in the lung","volume":"1257","author":"Frank","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1405","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.copbio.2010.07.003","article-title":"Chemical vectors for gene delivery: uptake and intracellular trafficking","volume":"21","author":"Pichon","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1410","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/156652306779010688","article-title":"Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import","volume":"6","author":"Vaughan","year":"2006","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1415","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1420","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1425","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1223012","article-title":"A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia","volume":"337","author":"Button","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1430","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","article-title":"\u201cStealth\u201d adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung","volume":"75","author":"Croyle","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1435","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1440","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1445","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI8858","article-title":"Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia","volume":"105","author":"Drapkin","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1450","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-5793(00)02236-5","article-title":"A novel peptide, THALWHT, for the targeting of human airway epithelia","volume":"489","author":"Jost","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1455","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/hum.2008.117","article-title":"Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells","volume":"19","author":"White","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1460","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/mt.2008.38","article-title":"A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer","volume":"16","author":"Tagalakis","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1465","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.biomaterials.2007.04.011","article-title":"Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells","volume":"28","author":"Elfinger","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1470","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1165\/ajrcmb.20.5.3417","article-title":"Enhanced efficiency of lactosylated poly-l-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells","volume":"20","author":"Kollen","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1475","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.01.012","article-title":"Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo","volume":"135","author":"Elfinger","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1480","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1485","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1490","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1495","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the tropism of lentiviral vectors through pseudotyping","volume":"5","author":"Cronin","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1505","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering targeted viral vectors for gene therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1510","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/gt.2012.20","article-title":"Directed evolution of novel adeno-associated viruses for therapeutic gene delivery","volume":"19","author":"Bartel","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1515","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.0813365106","article-title":"Directed evolution of adeno-associated virus to an infectious respiratory virus","volume":"106","author":"Excoffon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1520","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/mt.2009.155","article-title":"Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium","volume":"17","author":"Li","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1525","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/hum.2009.056","article-title":"Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia","volume":"21","author":"Granio","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1530","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/79463","article-title":"Efficient gene transfer to airway epithelium using recombinant Sendai virus","volume":"18","author":"Yonemitsu","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1535","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1099-0496(199609)22:3<161::AID-PPUL4>3.0.CO;2-S","article-title":"Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with Nacystelyn and rhDNase","volume":"22","author":"Dasgupta","year":"1996","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1540","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1545","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2217\/nnm.10.123","article-title":"Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine","volume":"6","author":"Suk","year":"2011","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1550","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.gt.3302968","article-title":"Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways","volume":"14","author":"Kushwah","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1555","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5b00794","article-title":"A new class of safe oligosaccharide polymer therapy to modify the mucus barrier of chronic respiratory disease","author":"Pritchard","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1560","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1565","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1165\/rcmb.2013-0050OC","article-title":"Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease","volume":"49","author":"Graeber","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1570","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.09-2017","article-title":"Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis","volume":"137","author":"Daviskas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1575","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1580","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2015.04.040","article-title":"Enema ion compositions for enhancing colorectal drug delivery","volume":"209","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1585","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302548","article-title":"Mechanism of efficient transfection of the nasal airway epithelium by hypotonic shock","volume":"12","author":"Lemoine","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1590","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1152\/jappl.1996.81.1.491","article-title":"Transient permeabilization of airway epithelium by mucosal water","volume":"81","author":"Widdicombe","year":"1996","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1595","doi-asserted-by":"crossref","first-page":"40020","DOI":"10.1074\/jbc.M307603200","article-title":"Increased vesicle recycling in response to osmotic cell swelling. Cause and consequence of hypotonicity-provoked ATP release","volume":"278","author":"van der Wijk","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1600","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s004120050384","article-title":"Nuclear organization studied with the help of a hypotonic shift: its use permits hydrophilic molecules to enter into living cells","volume":"108","author":"Koberna","year":"1999","journal-title":"Chromosoma"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1605","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/hum.1996.7.8-933","article-title":"Intraluminal water increases expression of plasmid DNA in rat lung","volume":"7","author":"Sawa","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1610","doi-asserted-by":"crossref","first-page":"F1411","DOI":"10.1152\/ajprenal.00244.2006","article-title":"Physiological significance of hypotonicity-induced regulatory volume decrease: reduction in intracellular Cl\u2212 concentration acting as an intracellular signaling","volume":"292","author":"Miyazaki","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1615","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(92)90348-P","article-title":"Exocytosis upon osmotic swelling in human epithelial cells","volume":"1107","author":"Okada","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1620","doi-asserted-by":"crossref","first-page":"C935","DOI":"10.1152\/ajpcell.00069.2003","article-title":"Hypotonicity induces membrane protrusions and actin remodeling via activation of small GTPases Rac and Cdc42 in Rat-1 fibroblasts","volume":"285","author":"Carton","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1625","doi-asserted-by":"crossref","first-page":"C1705","DOI":"10.1152\/ajpcell.00245.2002","article-title":"Maxi K+ channel mediates regulatory volume decrease response in a human bronchial epithelial cell line","volume":"283","author":"Fernandez-Fernandez","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1630","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1089\/hum.1998.9.18-2661","article-title":"Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent","volume":"9","author":"Parsons","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1635","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1525-0016(02)00021-7","article-title":"Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo","volume":"7","author":"Grogory","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1640","doi-asserted-by":"crossref","first-page":"C978","DOI":"10.1152\/ajpcell.1990.259.6.C978","article-title":"Role of calcium in tight junction formation between epithelial cells","volume":"259","author":"Gonzalez-Mariscal","year":"1990","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1645","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1165\/ajrcmb.22.2.3938","article-title":"Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo","volume":"22","author":"Wang","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1650","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/104303403765255138","article-title":"Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo","volume":"14","author":"Johnson","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1655","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.257.5073.1083","article-title":"An animal model for cystic fibrosis made by gene targeting","volume":"257","author":"Snouwaert","year":"1992","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1660","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng0593-35","article-title":"Production of a severe cystic fibrosis mutation in mice by gene targeting","volume":"4","author":"Ratcliff","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1665","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng0396-280","article-title":"Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor","volume":"12","author":"Rozmahel","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1670","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02513027","article-title":"Successful targeting of the mouse cystic fibrosis transmembrane conductance regulator gene in embryonal stem cells","volume":"1","author":"Dorin","year":"1992","journal-title":"Transgenic Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1675","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/2.10.1561","article-title":"A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus","volume":"2","author":"O'Neal","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1680","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng0895-445","article-title":"Generation and characterization of a delta F508 cystic fibrosis mouse model","volume":"10","author":"Colledge","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1685","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/j.1460-2075.1996.tb00432.x","article-title":"Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations","volume":"15","author":"Delaney","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1690","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/hmg\/11.3.243","article-title":"The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics","volume":"11","author":"Dickinson","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1695","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/physiolgenomics.00206.2005","article-title":"Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls","volume":"25","author":"Guilbault","year":"2006","journal-title":"Physiol. Genomics"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2016.05.031_bb1700","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcf.2004.05.039","article-title":"Animal models of cystic fibrosis","volume":"3","author":"Scholte","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2006-0184TR","article-title":"Cystic fibrosis mouse models","author":"Guilbault","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1710","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1513\/pats.2306015","article-title":"Submucosal glands and airway defense","volume":"1","author":"Wine","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1715","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1074\/jbc.271.9.4725","article-title":"Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator","volume":"271","author":"Ismailov","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1720","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/embo-reports\/kve232","article-title":"The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl\u2212 concentration","volume":"2","author":"K\u00f6nig","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1725","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1074\/jbc.272.22.14037","article-title":"Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics","volume":"272","author":"Stutts","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1730","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1152\/physiolgenomics.00185.2011","article-title":"Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction","author":"Livraghi-Butrico","year":"2012","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1735","series-title":"Mucosal Immunology","first-page":"397","article-title":"Mucus Clearance, MyD88-dependent and MyD88-independent Immunity Modulate Lung Susceptibility to Spontaneous Bacterial Infection and Inflammation","author":"Livraghi-Butrico","year":"2012"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1740","first-page":"L469","article-title":"Loss of Cftr function exacerbates the phenotype of Na(+) hyperabsorption in murine airways","volume":"304","author":"Livraghi-Butrico","year":"2013","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1745","first-page":"L944","article-title":"Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice","volume":"287","author":"van Heeckeren","year":"2004","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1750","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ijmm.2010.08.012","article-title":"Murine models of acute and chronic lung infection with cystic fibrosis pathogens","volume":"300","author":"Bragonzi","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1755","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.1163600","article-title":"Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs","volume":"321","author":"Rogers","year":"2008","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1760","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1126\/scitranslmed.3000928","article-title":"Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth","volume":"2","author":"Stoltz","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1765","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.M111.336537","article-title":"Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator","volume":"287","author":"Fisher","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1770","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7827-1-83","article-title":"Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer","volume":"1","author":"Li","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1775","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI43052","article-title":"Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis","volume":"120","author":"Sun","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091253","article-title":"Characterization of defects in ion transport and tissue development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-knockout rats","volume":"9","author":"Tuggle","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1785","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-61779-120-8_19","article-title":"Comparative biology of cystic fibrosis animal models","volume":"742","author":"Fisher","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1790","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCP.0b013e32834b14c9","article-title":"New animal models of cystic fibrosis: what are they teaching us?","volume":"17","author":"Keiser","year":"2011","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1795","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.gt.3303014","article-title":"Comparative biology of rAAV transduction in ferret, pig and human airway epithelia","volume":"14","author":"Liu","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1800","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/mt.2011.292","article-title":"Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles","volume":"20","author":"Mueller","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1805","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/labinvest.3700629","article-title":"In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA","volume":"87","author":"Cruz","year":"2007","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1810","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI113580","article-title":"Multiple tissues express alpha 1-antitrypsin in transgenic mice and man","volume":"82","author":"Carlson","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1815","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI113999","article-title":"Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice","volume":"83","author":"Carlson","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1820","first-page":"137","article-title":"Neonatal growth delay in alpha-1-antitrypsin disease. Influence of genetic background","volume":"6","author":"Dycaico","year":"1989","journal-title":"Mol. Biol. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1825","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1101\/gad.1.2.161","article-title":"Species- and tissue-specific expression of human alpha 1-antitrypsin in transgenic mice","volume":"1","author":"Kelsey","year":"1987","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1830","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1093\/nar\/15.18.7519","article-title":"The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice","volume":"15","author":"Ruther","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1835","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/nar\/15.4.1459","article-title":"Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice","volume":"15","author":"Sifers","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1840","first-page":"1375","article-title":"Alpha 1-antitrypsin deficiency and increased susceptibility to elastase-induced experimental emphysema in a rat model","volume":"120","author":"Blackwood","year":"1979","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1845","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/thorax.56.12.972","article-title":"Animal models of chronic obstructive pulmonary disease","volume":"56","author":"Dawkins","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1850","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00039896.1965.10664169","article-title":"Experimental emphysema: its production with papain in normal and silicotic rats","volume":"11","author":"Gross","year":"1965","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1855","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nm0697-675","article-title":"Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats","volume":"3","author":"Massaro","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1860","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2213-2600(12)70060-7","article-title":"Chronic obstructive pulmonary disease and comorbidities","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1865","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pupt.2005.06.001","article-title":"Murine models of COPD","volume":"19","author":"Brusselle","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1870","doi-asserted-by":"crossref","first-page":"L612","DOI":"10.1152\/ajplung.00390.2007","article-title":"Mechanisms of cigarette smoke-induced COPD: insights from animal models","volume":"294","author":"Churg","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1875","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphys.2013.00030","article-title":"Second hand smoke and COPD: lessons from animal studies","volume":"4","author":"Goldklang","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1880","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2009.10.022","article-title":"Current concepts on oxidative\/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease","volume":"254","author":"Yao","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1885","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.200404-511OC","article-title":"Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse","volume":"170","author":"Churg","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1890","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1165\/rcmb.2008-0038OC","article-title":"The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling","volume":"40","author":"Churg","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1895","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2012.11.053","article-title":"A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis","volume":"131","author":"Beckett","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1900","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.00081409","article-title":"Infection as a comorbidity of COPD","volume":"35","author":"Sethi","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1905","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17460441.2014.909805","article-title":"Animal models of chronic obstructive pulmonary disease","volume":"9","author":"Fricker","year":"2014","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1910","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1203\/00006450-198609000-00009","article-title":"Effect of passive smoking on the lung of young lambs","volume":"20","author":"Stecenko","year":"1986","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1915","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1183\/09031936.06.00004206","article-title":"Characterisation of guinea pig precision-cut lung slices: comparison with human tissues","volume":"28","author":"Ressmeyer","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1920","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/BF02388115","article-title":"Localization of immunoreactive tissue kallikrein in the seromucous glands of the human and guinea-pig respiratory tree","volume":"25","author":"Poblete","year":"1993","journal-title":"Histochem. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1925","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/rccm.200306-727OC","article-title":"Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope","volume":"168","author":"Tanaka","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1930","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/ajrccm\/142.6_Pt_1.1422","article-title":"Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig","volume":"142","author":"Wright","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1935","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/15412555.2012.691999","article-title":"Pulmonary inflammatory reaction and structural changes induced by cigarette smoke exposure in the Guinea pig","volume":"9","author":"Dominguez-Fandos","year":"2012","journal-title":"Copd"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1940","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/01902140902822304","article-title":"Role for cathepsin K in emphysema in smoke-exposed guinea pigs","volume":"35","author":"Golovatch","year":"2009","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1945","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/08958370290084836","article-title":"Smoking cessation decreases the number of metaplastic secretory cells in the small airways of the Guinea pig","volume":"14","author":"Wright","year":"2002","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1950","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/01902149209020654","article-title":"Effect of long-term exposure to cigarette smoke on the small airways of the guinea pig","volume":"18","author":"Wright","year":"1992","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1955","first-page":"L17","article-title":"Smoke-induced emphysema in guinea pigs is associated with morphometric evidence of collagen breakdown and repair","volume":"268","author":"Wright","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1960","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/08958370701515563","article-title":"Airway remodeling in the smoke exposed guinea pig model","volume":"19","author":"Wright","year":"2007","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1965","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.121.5_suppl.188S","article-title":"A model of tobacco smoke-induced airflow obstruction in the guinea pig","volume":"121","author":"Wright","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1970","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1164\/rccm.200202-098OC","article-title":"Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs","volume":"166","author":"Wright","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1975","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/01902148.2014.908250","article-title":"Animal models in chronic obstructive pulmonary disease-an overview","volume":"40","author":"Marcelino","year":"2014","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1980","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1378\/chest.117.5_suppl_1.223S","article-title":"Animal models for COPD","volume":"117","author":"Shapiro","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2016.05.031_bb1985","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1183\/09031936.00087606","article-title":"Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease","volume":"29","author":"Shapiro","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1990","first-page":"233","article-title":"The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency","volume":"68","author":"Martorana","year":"1993","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2016.05.031_bb1995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.08.002","article-title":"Lessons learned from mice and man: mimicking human allergy through mouse models","volume":"155","author":"Graham","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2000","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/138945008784533561","article-title":"The \u201cclassical\u201d ovalbumin challenge model of asthma in mice","volume":"9","author":"Kumar","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pharmthera.2010.10.008","article-title":"Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance","volume":"130","author":"Stevenson","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/thx.53.10.849","article-title":"An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen","volume":"53","author":"Temelkovski","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000107054","article-title":"Modeling responses to respiratory house dust mite exposure","volume":"14","author":"Cates","year":"2007","journal-title":"Contrib. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2020","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1365-2222.2004.02097.x","article-title":"Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma","volume":"34","author":"Kumar","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1165\/rcmb.2006-0385OC","article-title":"Prolonged inhaled allergen exposure can induce persistent tolerance","volume":"36","author":"Van Hove","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2222.2007.02740.x","article-title":"Animal models of asthma","volume":"37","author":"Zosky","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/138945008784533534","article-title":"The guinea pig as an animal model for asthma","volume":"9","author":"Ricciardolo","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.drudis.2011.05.014","article-title":"Animal models of asthma: value, limitations and opportunities for alternative approaches","volume":"16","author":"Holmes","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.200308-1094OC","article-title":"Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling","volume":"169","author":"Johnson","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2050","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1183\/09031936.00022908","article-title":"House dust mite induces direct airway inflammation in vivo: implications for future disease therapy?","volume":"35","author":"De Alba","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2055","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.00069110","article-title":"Do the current house dust mite-driven models really mimic allergic asthma?","volume":"36","author":"Birrell","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/thoraxjnl-2011-200606","article-title":"The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation","volume":"67","author":"Post","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2065","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4049\/jimmunol.1301888","article-title":"Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice","volume":"192","author":"KleinJan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2070","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4049\/jimmunol.1202386","article-title":"Transcription factors GATA-3 and RORgammat are important for determining the phenotype of allergic airway inflammation in a murine model of asthma","volume":"190","author":"Ano","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.200601-079OC","article-title":"Transcription factors T-bet and GATA-3 regulate development of airway remodeling","volume":"174","author":"Kiwamoto","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/intimm\/dxh026","article-title":"Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response","volume":"16","author":"Tamauchi","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2085","first-page":"L1045","article-title":"Involvement of GATA-3-dependent Th2 lymphocyte activation in airway hyperresponsiveness","volume":"290","author":"Yamashita","year":"2006","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2090","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaci.2015.02.018","article-title":"Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma","volume":"136","author":"Homburg","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/sj.gt.3300419","article-title":"Gene therapy strategies for asthma","volume":"4","author":"Demoly","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1165\/rcmb.2005-0189OC","article-title":"Species-specific differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction","volume":"34","author":"Liu","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.gt.3303014","article-title":"Comparative biology of rAAV transduction in ferret, pig and human airway epithelia","volume":"14","author":"Liu","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2004.05.010","article-title":"Isolation and air-liquid interface culture of human large airway and bronchiolar epithelial cells","volume":"3","author":"Bals","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2115","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcf.2004.05.040","article-title":"Established cell lines used in cystic fibrosis research","volume":"3","author":"Gruenert","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2125","first-page":"L347","article-title":"Culture and transformation of human airway epithelial cells","volume":"268","author":"Gruenert","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2005.02.010","article-title":"Human respiratory epithelial cell culture for drug delivery applications","volume":"60","author":"Forbes","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-61779-120-8_18","article-title":"Primary epithelial cell models for cystic fibrosis research.","volume":"742","author":"Randell","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2140","first-page":"L25","article-title":"The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia","volume":"300","author":"Pezzulo","year":"2011","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2145","first-page":"L92","article-title":"Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?","volume":"296","author":"Kesimer","year":"2009","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/01902140903165265","article-title":"Primary bronchial epithelial cell culture from explanted cystic fibrosis lungs","volume":"36","author":"Brodlie","year":"2010","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2155","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1038\/mtm.2015.34","article-title":"Testing gene therapy vectors in human primary nasal epithelial cultures.","volume":"2","author":"Cao","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080257","article-title":"The impact of allergic rhinitis and asthma on human nasal and bronchial epithelial gene expression","volume":"8","author":"Wagener","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ygeno.2011.06.008","article-title":"Differential global gene expression in cystic fibrosis nasal and bronchial epithelium","volume":"98","author":"Ogilvie","year":"2011","journal-title":"Genomics"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2170","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2016.05.031_bb2175","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.05.031_bb2180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05098","article-title":"In vitro generation of human pluripotent stem cell derived lung organoids","volume":"4","author":"Dye","year":"2015","journal-title":"Elife"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:13:00Z","timestamp":1655961180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916303108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":436,"alternative-id":["S0168365916303108"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to inhaled gene therapy of obstructive lung diseases: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}